Stephanie Fradette

Company: Biogen Idec

Job title: Senior Medical Director, Clinical Development

Seminars:

Showcasing Clinical Findings for Toferson: Disease-Modifying Capabilities Targeting SOD1 Genetic Mutation 2:15 pm

Explaining ongoing clinical strategy in extended phase 3 clinical trials Outlining lessons learnt regarding clinical endpoints from interactions with regulatory authorities What is the future for therapies targeting familial ALS seeking approval?Read more

day: Day Two AM